Jane Street’s Larimar Therapeutics LRMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.49M | Sell |
554,007
-124,935
| -18% | -$499K | ﹤0.01% | 4684 |
|
|
2025
Q4 | $2.59M | Buy |
678,942
+256,230
| +61% | +$997K | ﹤0.01% | 4327 |
|
|
2025
Q3 | $1.37M | Buy |
422,712
+412,179
| +3,913% | +$1.55M | ﹤0.01% | 5666 |
|
|
2025
Q2 | $30.4K | Buy |
+10,533
| New | +$24.4K | ﹤0.01% | 9286 |
|
|
2025
Q1 | – | Sell |
-33,781
| Closed | -$131K | – | 10116 |
|
|
2024
Q4 | $131K | Sell |
33,781
-80,002
| -70% | -$528K | ﹤0.01% | 8641 |
|
|
2024
Q3 | $745K | Buy |
113,783
+50,622
| +80% | +$407K | ﹤0.01% | 6481 |
|
|
2024
Q2 | $458K | Buy |
63,161
+24,336
| +63% | +$186K | ﹤0.01% | 7171 |
|
|
2024
Q1 | $295K | Buy |
+38,825
| New | +$303K | ﹤0.01% | 7595 |
|
|
2023
Q3 | – | Sell |
-19,565
| Closed | -$61.2K | – | 9059 |
|
|
2023
Q2 | $61.2K | Sell |
19,565
-122,017
| -86% | -$498K | ﹤0.01% | 8171 |
|
|
2023
Q1 | $641K | Buy |
141,582
+113,627
| +406% | +$594K | ﹤0.01% | 5885 |
|
|
2022
Q4 | $115K | Buy |
+27,955
| New | +$95.4K | ﹤0.01% | 8019 |
|
|
2021
Q4 | – | Sell |
-12,001
| Closed | -$138K | – | 10513 |
|
|
2021
Q3 | $138K | Buy |
+12,001
| New | +$144K | ﹤0.01% | 9112 |
|
|
2020
Q1 | – | Sell |
-4,999
| Closed | -$67K | – | 5703 |
|
|
2019
Q4 | $67K | Buy |
+4,999
| New | +$47.8K | ﹤0.01% | 4884 |
|
|
2019
Q3 | – | Sell |
-9,305
| Closed | -$133K | – | 5483 |
|
|
2019
Q2 | $133K | Buy |
+9,305
| New | +$248K | ﹤0.01% | 4795 |
|
|
2019
Q1 | – | Sell |
-1,667
| Closed | -$99K | – | 5373 |
|
|
2018
Q4 | $99K | Buy |
+1,667
| New | +$165K | ﹤0.01% | 4626 |
|
|
2016
Q2 | – | Sell |
-1,273
| Closed | -$102K | – | 4363 |
|
|
2016
Q1 | $102K | Buy |
+1,273
| New | +$100K | ﹤0.01% | 3878 |
|
Other funds holding LRMR
DM
BOCH
ACM
DCM
VCM
DCM
DTC